NDC 17478-605

COSOPT

Dorzolamide Hydrochloride And Timolol Maleate

COSOPT is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Akorn. The primary component is Dorzolamide Hydrochloride; Timolol Maleate.

Product ID17478-605_403490d6-b3a4-429b-93cf-ee22c05a9ab0
NDC17478-605
Product TypeHuman Prescription Drug
Proprietary NameCOSOPT
Generic NameDorzolamide Hydrochloride And Timolol Maleate
Dosage FormSolution/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date2014-04-30
Marketing CategoryNDA / NDA
Application NumberNDA020869
Labeler NameAkorn
Substance NameDORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE
Active Ingredient Strength20 mg/mL; mg/mL
Pharm ClassesCarbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 17478-605-10

1 BOTTLE, DROPPER in 1 CARTON (17478-605-10) > 10 mL in 1 BOTTLE, DROPPER
Marketing Start Date2014-04-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 17478-605-10 [17478060510]

COSOPT SOLUTION/ DROPS
Marketing CategoryNDA
Application NumberNDA020869
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2014-04-30

Drug Details

Active Ingredients

IngredientStrength
DORZOLAMIDE HYDROCHLORIDE20 mg/mL

OpenFDA Data

SPL SET ID:b7aa1986-1c24-4733-96b3-e6d8e1d44558
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1923433
  • 1923432
    • UPC Code
  • 0317478605102

    • Pharmacological Class

    • Carbonic Anhydrase Inhibitor [EPC]
    • Carbonic Anhydrase Inhibitors [MoA]
    • Adrenergic beta-Antagonists [MoA]
    • beta-Adrenergic Blocker [EPC]
    • Carbonic Anhydrase Inhibitor [EPC]
    • Carbonic Anhydrase Inhibitors [MoA]
    • Adrenergic beta-Antagonists [MoA]
    • beta-Adrenergic Blocker [EPC]

    Medicade Reported Pricing

    17478060510 COSOPT EYE DROPS

    Pricing Unit: ML | Drug Type:

    NDC Crossover Matching brand name "COSOPT" or generic name "Dorzolamide Hydrochloride And Timolol Maleate"

    NDCBrand NameGeneric Name
    17478-605COSOPTDorzolamide Hydrochloride and Timolol Maleate
    17478-604COSOPT PFDorzolamide Hydrochloride and Timolol Maleate
    55545-1007Dorzolamide and TimololDorzolamide Hydrochloride and Timolol Maleate
    17478-514Dorzolamide HCl and Timolol MaleateDorzolamide Hydrochloride and Timolol Maleate
    50090-2867Dorzolamide HCl and Timolol MaleateDorzolamide Hydrochloride and Timolol Maleate
    24208-486Dorzolamide Hydrochloride and Timolol MaleateDorzolamide Hydrochloride and Timolol Maleate
    50090-1247Dorzolamide Hydrochloride and Timolol MaleateDorzolamide Hydrochloride and Timolol Maleate
    50383-233Dorzolamide Hydrochloride and Timolol MaleateDorzolamide Hydrochloride and Timolol Maleate
    50383-261Dorzolamide Hydrochloride and Timolol MaleateDorzolamide Hydrochloride and Timolol Maleate
    60429-115Dorzolamide Hydrochloride and Timolol MaleateDorzolamide Hydrochloride and Timolol Maleate
    42571-147Dorzolamide Hydrochloride and Timolol Maleate ophthalmic SolutionDorzolamide Hydrochloride and Timolol Maleate

    Trademark Results [COSOPT]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    COSOPT
    COSOPT
    74714427 2173319 Live/Registered
    MERCK SHARP & DOHME CORP.
    1995-08-11
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.